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Abstract
Because bone-associated diseases are increasing, a variety of tissue engineering approaches with bone regeneration
purposes have been proposed over the last years. Bone tissue provides a number of important physiological and structural
functions in the human body, being essential for hematopoietic maintenance and for providing support and protection of vital
organs. Therefore, efforts to develop the ideal scaffold which is able to guide the bone regeneration processes is a relevant
target for tissue engineering researchers. Several techniques have been used for scaffolding approaches, such as diverse
types of biomaterials. On the other hand, metallic biomaterials are widely used as support devices in dentistry and orthopedics,
constituting an important complement for the scaffolds. Hence, the aim of this review is to provide an overview of the degradable
biomaterials and metal biomaterials proposed for bone regeneration in the orthopedic and dentistry fields in the last years.
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Introduction
Tissue engineering is proving to be a promising field.
It consists of the association of cells, biomaterials, and
bioactive factors in order to mimic the native tissue, aiming
to restore, maintain, or improve tissue function. Bone
tissue engineering aims to develop three-dimensional
scaffolds to provide the necessary structural support for
the formation of a new bone structure, where usually the
addition of growth factors and cells contributes to the
acceleration of the osteogenic lineage induction.
Bone tissue, when intact, performs critical functions
for the human body. It is directly related to locomotion
because of the mechanical support that it provides for the
body. In addition, bone is responsible for maintaining
mineral homeostasis and because of its rigidity, it is the
foremost protective barrier of vital organs. As a result of
being an active multifunctional tissue, bones are suscep-
tible to injury, which could compromise their function.
Orthopedic and dental bone defects are common
problems that can occur due to trauma, infections, neo-
plasms, congenital conditions, or simply by aging. There-
fore, grafts are necessary to replace injured tissue,
ensuring a close connection between the implant and
the host bone. The materials used in this process must
provide an ideal structural environment for cells that
participate in the bone healing process.
Autogenous bone is considered the ‘‘gold standard’’
for bone regeneration due to its osteogenic, osteoconduc-
tive, and osteoinductive properties. However, its use
depends on bone availability, with disadvantages such
as the risk of vascular-nervous lesions and morbidity in
the recipient bed, thereby limiting its use (1). A less
invasive alternative are xenogenic, allogeneic, and allo-
plastic bone grafts.
The restrictions of xenogenous grafts are their limited
capacity to be fully incorporated into the native bone,
being present in the implanted area for long periods of
time, in addition to the risk of rejection or disease trans-
mission. Allogeneic bone exhibits reduced osteoinductive
properties and such grafts have a risk of immunoreactions
and transmission of infections (2).
Alloplastic biomaterials have been widely studied in
tissue engineering including ceramics, polymers, and metals
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and these materials can be associated with growth factors
or cells. This type of graft has been investigated due to
its advantages such as easy handling, great availability of
shapes and sizes, and a high variety of resources for its
production. In addition, the use of alloplastic biomaterials
contributes to the reduction of surgical morbidity, absence of
antigenicity, and risk of disease transmission (3).
Research studies involving the development of scaf-
folds for bone regeneration have increased considerably
over the last fifteen years, and since 2013, the number of
publications has remained between 200 and 299 per year,
as can be seen in Figure 1. The number of publications
related to metals and bone regeneration has also been
high over the years, but since 2014, the number of publi-
cations involving scaffolds is comparable to that of metals.
Currently, there are several techniques in tissue
engineering used to develop scaffolds with different
purposes. Some of these techniques are solvent casting,
particulate leaching, freeze-drying, gas foaming, powder-
forming, sol-gel technique, electrospinning, and 3D print-
ing. For metal biomaterials, the efforts are focused on
surface treatment to promote osseointegration.
The aim of this review was to provide an overview of
the biomaterials proposed for bone regeneration in the
orthopedic and dentistry fields in the last years. This
review focuses mainly on degradable biomaterials, with-
out disregarding the important role of metals in orthope-
dics and dentistry.
Degradable biomaterials for bone
regeneration in orthopedics
Orthopedic regenerative medicine aims to design bone
scaffolds and implants able to replicate the biomechanical
properties of the host bone. For bone regeneration, a
scaffold should be biodegradable and biocompatible,
as well as having osteoconductive, osteoinductive, and
osteogenic properties (4). In addition, it is desirable that it
provides an appropriate exchange of nutrients, promotes
vascularization and bone ingrowth, and has a pore size
ranging from 100 to 500 mm (5).
Manufacturing techniques for bone scaffolds
Figure 2 shows that in the last 10 years the most cited
technique for the development of bone tissue regeneration
scaffolds has been freeze-drying, followed by electrospin-
ning, three-dimensional printing, and particulate leaching.
Three-dimensional printing, also known as additive
manufacturing, is a technology that has been widely used
in bone tissue engineering. It is a fast and strict process
that consists of depositing materials layer by layer to
produce 3D objects (6). The printed porous scaffold can
have controlled parameters, being able to increase the
reproducibility of the structure.
Recently, the development of three-dimensional scaf-
folds based on laser-cutting manufacturing process
has been proposed (7). This technique consists of the
generation of sheet-based scaffolds in which single sheets
Figure 2. Distribution of manufacturing techniques cited for
scaffolds with a bone regeneration objective. Each term has been
associated with AND ‘‘Bone Regeneration’’[MeSH]. June 1, 2020.
Figure 1. The number of annual publications in the PubMed database from 2005 to May 2020 using the terms: (Bone Regeneration
[MeSH Terms]), (Tissue Scaffolds[MeSH Terms]) and (Metals). November 16, 2020. BR: bone regeneration.
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are manufactured and cut by a high precision laser that
uses templates generated by computer-aided design
(CAD). The sheets are then stacked to form a 3D scaffold.
The advantages of this technique are that single sheets
can be seeded with cells before being stacked, allowing
for a spatially uniform cell distribution, as an appropriate
cell distribution is difficult to obtain with solid scaffolds.
Using the solvent casting-particulate leaching method,
highly porous scaffolds with good interconnections be-
tween each pore can be formed, but it can only be used to
produce thin membranes of 3–4 mm. This process con-
sists of the mixture of a polymer solution and salt crystals
with specific dimensions, followed by evaporation of
the organic solvent. The remaining salt particles with
the polymer matrix are then leached out by immersion
in water, which dissolves the particles and produces a
porous structure (8).
Freeze-drying is another technique used to manufac-
ture high porosity polymeric scaffolds in which the polymer
solution is frozen, leading to the solidification of the
organic solvent that will be later removed by sublimation.
Concentration of the polymer solution and the freezing
temperature can influence the distribution of the pores and
the pore size, enabling the creation of a wide variety of
scaffolds with different pore structures (9). As a result,
a 3D structure with interconnected pores is developed,
although it has low mechanical stability and requires the
use of toxic solvents.
Fibrous scaffolds provide a similar architecture to that
of the extracellular matrix. Electrospinning is a method that
creates an electrically charged jet of a polymer solution
through a high voltage system, producing fibers with a
thin diameter and a large surface area (10). Natural and
synthetic polymers are used to fabricate the nanofiber
structure, creating a three-dimensional environment that
could be beneficial for cell attachment and proliferation.
However, with the electrospinning technique, small pores
are formed, and the porogen technique is not an option for
larger structures as porogens need to be totally removed (7).
Three-dimensional printing can also be associated
with other techniques, such as freeze-drying, to enhance
the mechanical properties and biocompatibility of the
scaffold. Kankala and colleagues elaborated a poly
(lactide-co-glycolide) (PLGA) scaffold using the extrusion
3D printing technique and immersed it in a gelatin/nano-
hydroxyapatite solution (11). The scaffolds were frozen
and lyophilized, resulting in a more hydrophilic scaffold
with enhanced mechanical properties and biocompatibil-
ity, as well as presenting an increased level of alkaline
phosphatase activity and higher osteocalcin content. Their
study exemplifies an ingenious association of techniques
and polymers to achieve a functional scaffold.
Composition of bone regeneration scaffolds
In regard to biomaterials composition, Figure 3 shows
that in the last 10 years, collagen was the most cited
polymer for the development of bone tissue regeneration
scaffolds, followed by gelatin, chitosan, PLGA, polycapro-
lactone, alginates, hyaluronic acid, and polyvinyls. In the
case of ceramics, Figure 4 shows that hydroxyapatite (HA)
was the most cited ceramic in studies related to bone
regeneration, followed by calcium phosphate (CaP), and
glass.
Bioactive ceramics and polymers can be classified as
biomaterials due to their compatibility with living tissue.
Furthermore, natural and synthetic ceramics are resistant
to corrosion and can stimulate new bone formation but are
very fragile and have low abrasion resistance. Ceramic
biomaterials can include bioactive glasses, HA, calcium
Figure 3. Graph showing polymer distribution in publications
retrieved from a search in the PubMed database with the terms:
‘‘Chitin’’[MeSH], ‘‘Collagen’’[MeSH], ‘‘Gelatin’’[MeSH], ‘‘Alginates’’
[MeSH], ‘‘Hyaluronic Acid’’[MeSH], ‘‘Polycaprolactone’’ [Supple-
mentary Concept], ‘‘Polyvinyls’’[MeSH], ‘‘Polylactic Acid-Polygly-
colic Acid Copolymer’’[MeSH]. Each term has been associated with
AND ‘‘Bone Regeneration’’ [MeSH]. June 1, 2020.
Figure 4. Graph showing ceramic distribution in publications
retrieved from a search in the PubMed database using the
following terms: ‘‘Hydroxyapatites’’[MeSH], ‘‘Calcium Phosphate’’
[MeSH], ‘‘Glass’’]MeSH]. Each term has been associated with
AND ‘‘Bone Regeneration’’ [MeSH]. June 1, 2020.
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silicon, b-tricalcium phosphate (b-TCP), and biphasic
calcium phosphate (BCP) (12).
Calcium phosphate-based ceramics are widely used
for the fabrication of scaffolds for bone tissue engineering
as calcium phosphate is abundant in native human bone.
HA is the most frequently used bioceramic in the
orthopedic field because of its excellent biocompatibility
and osteoconduction properties (13). TCP is also com-
monly used in this field because it promotes proliferation
of osteoprecursor cells. This biomaterial has less stability
than HA and shows a faster degradation process and
higher solubility (14).
Besides the inorganic matrix, bone is mostly composed
of collagen. Therefore, many researchers have used
collagen scaffolds for bone regeneration purposes. Col-
lagen can provide a three-dimensional environment, which
mimics some bone-forming components and can also
increase cell proliferation. It can be associated with other
biomaterials, such as bioceramics, carbon, and polymers in
order to improve mechanical strength and bone repair (15).
Calabrese and collaborators showed in their study that
collagen associated with magnesium-enriched HA was
beneficial for osteogenic differentiation (16).
Synthetic polymers are also widely utilized to produce
scaffolds. In the orthopedics, some of the most common
ones are poly E-caprolactone (PCL), polyglycolic acid
(PGA), poly(lactide) (PLA), and PLGA. In addition to their
biodegradability, the physicochemical and mechanical
properties are comparable to native bone tissue. They
can also be easily modified to obtain desired properties
for different applications. In the research conducted by
Lee and collaborators, PCL and PLGA were associated
with TCP and a ceramic material made of sintered and
ground duck beak. The study shows that the bone volume
percentage of the PCL/PLGA/TCP and PCL/PLGA/duck
beak scaffold groups is significantly higher than those of
the control groups (17).
In recent years, there has been a growing interest in
metal ions for bone scaffold purposes due to their bio-
degradability and biocompatibility, besides having impor-
tant roles in tissues physiology. Magnesium (Mg-), iron
(Fe), zinc, and their alloys have been the most studied.
Wu et al. (18) proposed a three-dimensional composite
scaffold with HA and magnesium oxide embedded in fiber
of silkworm cocoon and silk fibroin. The addition of 1wt.%
MgO led to the release of magnesium ions, which created
a weak alkaline environment that improved the prolifera-
tion and osteogenic differentiation of bone marrow stem
cells (BMSCs) in vitro, as well as promoted in vivo bone
formation. The authors found that a pH between 7.2–8.5
could promote the proliferation of the BMSCs. On the
other hand, zinc incorporation in a synthetic hydrogel-
amorphous calcium phosphate composite resulted in a
significant increase of extracellular matrix mineralization
after 21 days of BMSC culture in a study conducted by
Chahal et al. (19).
A summary of the relevant studies in the last ten years
is presented in Table 1 (11,17,20–28). To elaborate this
table, a search in the PubMed database was performed
with the formula: ((‘‘Bone Regeneration’’[MeSH]) AND
‘‘Tissue Scaffolds’’[MeSH]) AND ‘‘Orthopedic Proce-
dures’’[MeSH]. The search with the 10-year filter resulted
in 147 articles (29 reviews).
Animal models
Numerous in vivo experiments have been conducted
in order to prove the effectiveness of the association of
scaffolds and stem cells. The analyzed studies in Table 1
demonstrated that rabbits and rats are the most common
animals tested in the orthopedic field. In the study carried
out by Wang and collaborators (20), rabbits were used as
animal models for treating bone defects in the femur. They
proposed an association of b-TCP ceramic scaffold and
mesenchymal stem cells (MSC). When the femoral vas-
cular bundle was fixed into the side groove of the scaffold
seeded with MSC, a higher new bone formation percent-
age and better vascularization were seen. Li et al. (21)
followed the same strategy with the same animal model
but combining the stem cells with different biomaterials
and bone morphogenetic proteins (BMP-2), increasing
new bone formation. Femoral defects were also con-
ducted in rats, as shown in the study by Johnson and col-
laborators (29) using polycaprolactone/collagen/heparin
scaffolds with the incorporation of BMP-2. Radial bone
defect model in rabbits and rat calvaria defect are also
frequently used. In vivo studies with sheep and pigs are
still found although less frequently.
Clinical trials
Synthetic scaffolds based on HA and bTCP have been
the most used in clinical studies in orthopedics. Jäger and
collaborators investigated the potency of bone marrow
aspiration concentrate (BMAC) to augment bone graft-
ing and support bone healing in local bone defects with a
defect area (length  width) measurement larger than
11 cm. The BMAC was mixed with porous hydroxyapa-
tite granules (Orthosss) (n=27) or applied onto a collagen
sponge (Gelaspons) (n=12). The results show that
BMAC-HA has complete bone healing faster than the
group of BMAC-collagen and also that the postoperative
bone formation appeared earlier in the HA group (30).
In 2016, Šponer et al. (31) reported a prospective,
controlled clinical trial (n=9) utilizing expanded autologous
MSCs on a ultraporous b tricalcium phosphate synthetic
graft material (Vitosss) for femoral defects. The associa-
tion of the bTCP with MSCs increased the trabecula and
decreased the radiolucency within the defect. Later in
2018, Šponer et al. (32) reported a prospective study,
this time with 19 patients for the MSCs/bTCP group and
using a control group treated with cancellous allografts.
No significant difference was observed between femo-
ral defect healing in the MSCs/bTCP group and the
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cancellous allograft group. However, significant differ-
ences were documented between the bTCP group and
the cancellous allograft group.
The use of scaffolds in the clinical field has shown
good results for bone regeneration purposes; however,
translational difficulties still exist and more clinical studies
Table 1. Summary of relevant studies involving scaffolds for bone regeneration in the orthopedic field in the last ten years.
Reference,
year
Scaffold Cells Additive Manufacturing
technique
Study type Results
(20) 2010 b-TCP BMSCs – – Femur defects in
rabbits (n=64)
Prevascularized tissue-engineered bone
grafts led to significantly higher volume of
regenerated bone and larger amount of
capillary infiltration




Solid fusion in PCL/TCP/BMP-2 group
comparable to autograft bone
(23) 2013 HA Sintlife, Engipore MSCs – Slurry expansion In vitro Non-stoichiometric MG(2+) and
stoichiometric apatites, in granular form,
represent a more favorable environment for
the growth of cells compared to a non-
stoichiometric Mg(2+) apatite, in
nanostructured paste.
(24) 2014 Cortical part: Silicon
carbide (BioSiC)/Collagen/








PRP or BMSCs did not further improve
the osteotomy healing. Significantly
higher values in periosteal callus score
in the BioSiC(HaCol)+BMSC group




Scaffolds constructed by perfusion seeding
and perfusion culture method exhibited
better biological properties, significantly
higher new bone formation and greater
mechanical properties.
(26) 2015 Bioactive glass – – Melting and
homemade fiber
tower
Study in rat with
tibial defect
(n=10)
Similar amount of newly formed bone
compared with the control group and
enhanced expression of RUNX-2 and
RANK-L









Bone volume percentage of the PCL/PLGA/
TCP and PCL/PLGA/duck beak scaffold
groups was significantly higher compared




BMSCs – – Study in rat
with femoral
defect (n=10)
The hydrogel showed significant osteogenic
properties and rapid resorption.












The scaffold was able to improve new
bone formation, increasing cell proliferation
and osteogenesis, and angiogenesis effects.
(28) 2019 Hyperelastic bone (HA and
PLGA)






New bone formation surrounding the scaffold








In vitro Enhanced hydrophilicity, mechanical
properties and biocompatibility. Increased
level of alkaline phosphatase activity. Higher
osteocalcin content. Promotion of the
secretion of collagen I.
b-TCP: b-tricalcium phosphate; BMSCs: bone marrow stromal cells; PCL: polycaprolactone; PLGA: poly(lactic-co-glycolic acid); BMP-2:
bone morphogenetic protein 2; HA: hydroxyapatite; MSCs: mesenchymal stromal cells; PRP: platelet-rich plasma; RUNX-2: runt-related
transcription factor 2; RANK-L: receptor activator of nuclear factor-kappa b ligand; MC3T3-E1: osteoblastic cell line.
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are necessary for the implementation of scaffolds in
clinical practice.
Degradable biomaterials for bone
regeneration in dentistry
Bone regeneration is one of the most important and
challenging tissue engineering approaches in regenera-
tive medicine, being a promising technique in dentistry
as it is considered to be an ideal strategy for treating
diseases, injuries, and defects within the maxillofacial
region. More importantly, the principles of tissue engineer-
ing have been applied in several branches of dentistry,
such as oral maxillofacial surgery, periodontics, and
implant dentistry, with a wide variety of scaffolds available
for purchase on the market.
Tooth extraction caused by periodontal disease or
trauma, leading to alveolar bone loss are frequent
problems that dentists have to deal with. Bone resorption
of the residual ridge continues throughout life in edentu-
lous patients, being difficult to restore the missing teeth
with dental implants or prosthodontic approaches (33). In
addition, the occurrence of defects in maxillofacial bones
are common and can be caused by a range of factors
such as infections, congenital deformities, trauma, or
tumorectomy (34), which need to be treated for reposition
of tissue and restoration of function of the patient.
Therefore, tissue engineering techniques using scaffolds
for bone regeneration have become a frontier in dentistry,
looking towards the preservation of the periodontium and
the different bone regions of the maxillofacial complex.
In Table 2, a summary of relevant studies related to
scaffolds for bone regeneration in the dentistry field is
presented (35-45). A search was performed in the PubMed
database with the formula: ((‘‘Bone Regeneration’’[MeSH])
AND ‘‘Tissue Scaffolds’’[MeSH]) AND ‘‘Dentistry’’[MeSH]
on April 16, 2020 using the filter of the last ten years and
not considering reviews.
As shown in Table 2, several biomaterials have been
proposed for maxillofacial bone regeneration including
synthetic polymers such as PCL, PLLA, and PLGA,
calcium phosphate compounds such as bTCP, biphasic
calcium phosphate (HA/b-TCP), cyanoacrylate-combined
calcium phosphate (CCP), and HA and its compounds
such as MgHA or n-HA/PA. Natural polymers have also
been proposed such as collagen, hyaluronic acid, PRF,
ilk fibroin, gelatin, and chitosan, and even decellularized
matrices such as cartilage matrix or demineralized bone
matrix. However, only HA, TCP, inorganic bone matrix,
and collagen scaffolds have been widely evaluated clini-
cally as bone substitutes to date (33,46).
HA and TCP ceramics have a chemical and biological
similarity to bone tissue, providing good biocompatibility
and cell adhesion properties. TCP is a resorbable bio-
material with a faster degradation rate than bone regen-
eration (47). It has therefore been necessary to improve
its mechanical properties by the association with other
biomaterials such as HA or PCL (38,39,48). b-TCP
releases calcium ions into local tissue, which contributes
to the control of osteoblastic viability, proliferation, and
differentiation (49), indicating that calcium phosphate-
based materials present osteoconductivity properties.
A human clinical study with X-ray computed micro-
tomography (microCT) and histomorphometric analysis of
bone biopsies demonstrated that for sinus augmentation,
9 months after grafting a scaffold of HA/b-TCP 30/70
in granules or blocks, the block-based scaffold had a
significantly higher strut thickness and strut number,
closer to that of native healthy tissue (48). In addition, a
large amount of newly formed bone and a rich net of new
vessels was detected, which meant that not only the
scaffold composition but also the scaffold morphology
influences the quality of the regenerated tissue.
Although the sole implantation of scaffolds has brought
good results, studies have shown that planting stem cells
on scaffolds, previous to the implantation, contributes to
bone deposition and angiogenic stimulation, which could
be relevant in poor bone marrow sites such as the man-
dibular angle (38,39,41,50). Additionally, in cases where
dental implants are placed in junction with bone grafts,
bone-implant contact has also improved with the addition
of stem cells on the scaffold, contributing to primary
stability of the dental implant (49,51).
Growth factors like GDF-5, BMP-7, PDGF, and BMP-2
have also been incorporated onto scaffolds, improving
therapeutic potential and increasing the percentage of the
regenerated bone area (36,37,52).
Despite the latest technological advances achieved
in bone tissue scaffolds, autogenous bone is still the
gold standard in dentistry, but limitations related to bio-
availability and morbidity makes continuous research
necessary in order to develop a scaffold resembling the
autogenous bone matrix. However, Bayat and collabora-
tors used BMG to regenerate alveolar osseous defects in
cats, showing new bone formation and mineralization
superior to autogenous bone at day 56 (35). Additionally,
the use of calcium phosphate cement with the addition
of cryopreserved bone-derived osteoblasts has shown
results comparable to that of autogenous bone.
As in orthopedisc, three-dimensional printing in den-
tistry has assumed important relevance. It has many
advantages such as the possibility of direct printing in the
defective site, which means a faster scaffold preparation
with increased accuracy. It also allows the production of
scaffolds with different intricate shapes resembling the
lesion.
Recently, Lopez and collaborators developed a three-
dimensionally printed bioactive ceramic scaffold of b-TCP
coated with dipyridamole, an adenosine A2A receptor
indirect agonist, which could inhibit osteoclastogenesis.
They created a critical-size bone defect at the mandibular
rami of rabbits. Bone growth was evaluated by microCT.
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The results showed a larger percentage of bone in the
dipyridamole group, which means that incorporation of
dipyridamole increased the bioactivity of the scaffold (53).
Commercially available scaffolds
The collagen membranes type I or III from porcine or
bovine origin have been widely used for guided bone
regeneration, which consists of creating a barrier to
prevent the migration of soft tissue cells into the bone
graft. Without the presence of such a barrier, the cells
could invade the environment for the new bone formation
(50).
Analyzing the studies obtained after applying the same
formula cited above ((‘‘Bone Regeneration’’[MeSH]) AND
‘‘Tissue Scaffolds’’[MeSH]) AND ‘‘Dentistry’’[MeSH] on
April 4, 2020) on the PubMed database, it was found
that the composition of the majority of the scaffolds used
in the studies was the natural polymer collagen, and
Table 2. Summary of relevant studies involving scaffolds for bone regeneration in the dentistry field in the last ten years.
Reference,
year
Scaffold Cells Additive Manufacturing
technique
Study type Results
(35) 2010 BMG (bone matrix gelatin) 
autogenous bone graft
– – Freeze-drying Study in cats with
alveolar osseous
defects (n=4).
Greater levels of new formed bone in BMG group.
Only on day 56, the mean of bone density was
significantly higher in the BMG group.







The linear bone growth and percentage of bone
filling were significantly higher in the PDGF
+b-TCP group at 6 months compared with that in
the b-TCP group.




The overall mean of the percentage of
regenerated bone was considerably greater
when BMP-7 was incorporated.
(38) 2013 PCL/TCP (80:20)
(Osteopore)
BMSC – 3D printing Vertical alveolar
ridge defect in dogs’
mandible (n=4).
Early revascularization and higher amount of new
bone.
(39) 2015 b-TCP and Type I
collagen





enhanced periodontal tissue regeneration
compared with collagen and b-CP/collagen.
(40) 2015 Magnesium/PLGA – – Solvent casting,
salt leaching
Study in beagle dogs
with alveolar bone
defects (n=6).
Mg provided pH buffering properties to the
scaffold, as well as an osteoconductive








Highest new bone area value and new bone height
value compared with the control group. No
significant difference was shown with the
incorporation of the cells.





Study in rabbits with
calvaria defects
(n = 12).
Silk fibroin-coated scaffold demonstrated the
ability to induce new bone formation with low
inflammation and high vascularity.
(43) 2018 Nano-HA and collagen type I
(1:1)(Allgens)+Mg-Ca alloy
rods









The combined scaffold of mineralized collagen/
Mg-Ca alloy rods was more effective at reducing
the absorption of the alveolar ridge and preserving
the socket site than the mineralized collagen
alone.








in the jaw (n=12).
The scaffold suffered degradation along with the
regeneration of new tissue.












Enhanced angiogenesis and inhibition of
osteoclast activity. The scaffolds promoted MSC
osteogenic differentiation and bone formation
BMG: bone matrix gelatin; b-TCP: b-tricalcium phosphate; TCP: tricalcium phosphate PDGF: platelet-derived growth factor; BMSCs:
bone marrow stromal cells; PCL: polycaprolactone; PLGA: poly(lactic-co-glycolic acid); PLLA: poly(L-lactic acid); BMP-7: bone
morphogenetic protein 7; HA: hydroxyapatite; Mg: magnesium; Ca: calcium.
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commercially available scaffolds such as Olympus Ter-
umo Biomaterials, Parasorb cone, Terudermis, Bio-Gide,
CollaCote, BDt 3D Collagen Composite Scaffold, and
Mucograft were used. Also, tilapia type I collagen scaffold
has been studied showing promising results (54). Addi-
tionally, hybrid bone substitutes based on hydroxyapa-
tite/TCP were reported as Osteon II, Ceraforms, and
Reprobone.
Mineralized collagen has been studied due to its simi-
larity to the natural bone microstructure because it is com-
posed of nano-hydroxyapatite and collagen type I (1:1).
To compensate mechanical limitations, three Mg-Ca alloy
rods were inserted into mineralized collagen, a strategy that
allows for a successful overcoming of such a limitation (43).
For vertical fillings or socket filling, deproteinized
bovine bone is the scaffold most frequently used due to
its osteoconduction properties and bone neoformation
capacity. Although it is not fully reabsorbed by the body,
clinical success in regard to good structural support has
been reported in the scientific literature (55). Bio-Oss is an
example of this type of scaffold, being the commercial
scaffold of choice for many bone regeneration procedures
in dentistry. However, Mayer and collaborators demon-
strated that a bioactive bovine bone (Alpha Bio’s Graft)
scaffold reinforced with PCL caused a higher percentage
of new bone compared to Bio-Oss (56).
Animal models
Several animal model studies have been used to
evaluate scaffolds in which cats, rabbits, rats, and dogs
were used to develop various types of bone defects
(Table 2). Bone defects frequently used in the dentistry
field are alveolar osseous defects, peri-implant defects,
periodontal osseous defects, dehiscence type defects in
mandible, bone alveolar ridge defects, class III furcation
defects, calvaria defects, maxillary sinus floor augmenta-
tion, and mandibular branch defects, which are the most
frequent lesions that dentists have to deal with.
Scaffolds (BMG or magnesium/PLGA) without cells or
growth factors successfully promoted new bone formation
in models of alveolar bone defects in cats and dogs (35,40)
and also in models of peri-implantitis defects in rabbits
(scaffold silk fibroin powder/PRF) (57). Furthermore, in a
study using a periodontal defect model in dogs and a
chitosan/b-glycerophosphate scaffold, the incorporation of
BMSC did not represent a significant increase in new
bone area or new bone height (41), showing a similar per-
formance compared with the group without cells.
Clinical trials
Clinical studies with humans have demonstrated that
for bone regeneration of small bone defects, such as
alveolar bone defects (58) or some sinus augmentations
(48), the scaffold implantation is sufficient, without the
need of cells or growth factors. However, the use of cells
and growth factors could accelerate healing, as it is
interesting to reduce the waiting time between the
surgical-prosthetic steps (59). Rickert and collaborators
showed that for maxillary sinus floor elevation, the
incorporation of stem cells into a bovine bone mineral
scaffold (BioOsss) was a strategy as efficient as using
BioOsss mixed with autogenous bone (46). Nevertheless,
Chen et al. (60) showed that for periodontal defects, no
statistically significant difference was detected when stem
cells are incorporated into the BioOsss scaffold in a
randomized clinical trial.
Jayakumar et al. (36) carried out a human clinical study,
where patients presented periodontal osseous defects.
Their strategy to gain bone volume was to incorporate
PDGF into a scaffold of b-TCP. The results showed that
linear bone growth and percent of bone filling were
significantly higher in the PDGF-BB+b-TCP group at the
end of 6 months, compared with that in the b-TCP group.
Since there is a range of possibilities of techniques
and materials for the production of bone regeneration
scaffolds, further studies are suggested with a higher
number of patients and applying a randomization criterion.
In addition, it is necessary to establish which type of cells
and growth factors are more appropriate to be associated
with scaffolds and also to establish the most appropriate
technique for scaffold production according to the bone
morphology and localization.
Role of metallic biomaterials in orthopedics
and dentistry
Metallic biomaterials are widely used in orthopedics as
support devices, being mainly utilized for the manufacture
of plates, fixation screws, and orthopedic implants for the
replacement of missing joints or bones. In the dentistry
field, metallic biomaterials can be also used to manufac-
ture dental implants as well as metallic meshes for the
stabilization of bone grafts in guided bone regeneration.
Its rigidity provides space maintenance and avoids
collapse of the contour and displacement of the graft.
The success of a metallic implant in the human body is
directly related to biocompatibility and reduced immune
response. Despite the widespread use of metal implants,
they have some disadvantages and although being bio-
tolerable or bioinert, metal alloys can release particles due
to wear or chemical degradation, which could cause
different pathologies, requiring a posterior removal of the
implant (61), and even stimulate the metabolic pathways
of many cell types, including osteoclasts, osteoblasts,
lymphocytes, macrophages, or fibroblasts (62). In addi-
tion, the failure of implants can occur due to the difference
between the elastic modules of the metallic implants
and the host tissue, causing the phenomenon known as
‘‘stress shielding’’ (63).
Among the metallic biomaterials, the use of silver,
magnesium, cobalt, niobium, strontium, and titanium is
becoming prominent for application in bone regeneration in
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dentistry and orthopedics. However, for support elements,
titanium is the most commonly used (64) (Figure 5);
among the titanium alloys, Ti6Al4V is the best known,
being used in approximately 50% of the applications (65).
Titanium and its alloys are called ‘‘special metals’’ and
are considered ideal for implants as they have satisfactory
mechanical properties and resistance to corrosion. The
latter property is normally conferred to these materials
due to the occurrence of a spontaneous reaction with the
formation of a passive layer of TiO2 on its surface, which
acts as a protective barrier.
However, depending on the conditions of the medium,
titanium and its alloys can corrode very quickly or slowly
depending on the environment being anaerobic, where
water is the oxidizing agent, or aerobic, where oxygen is
the oxidizing agent. In the case of alloys, the thickness
of this oxide layer becomes a critical parameter because
it acts directly on controlling the release of metal ions
(66,67). If this layer is very thin, the release of these ions is
gradually facilitated, and thus it becomes less protective.
On the other hand, the thicker the layer is, the more likely
is crack formation, which will eventually lead to a pro-
nounced release (66). In extreme cases, corrosion can
cause a reduction in the mechanical performance, or even
fracture of the implant, reaching the surrounding tissue,
and consequently, the need for implant removal (67).
In the specific case of Ti6Al4V, some in vivo studies
have already shown the release of titanium ions by the
dissolution of implanted devices (68). The dissolution
of aluminum (Al) in the human organism can promote
pathologies such as the Alzheimer’s disease, peripheral
neuropathy, and osteomalacia. In addition, the presence
of vanadium (V) can alter the kinetics of enzyme activity
associated with the inflammatory response (69).
Another important factor in relation to titanium implants
and their alloys is that their surfaces constitute an ade-
quate environment for bacterial adhesion and prolifera-
tion, favoring the formation of biofilms that are largely
inaccessible to the immune system and resistant to
the action of drugs (70). Biofilm is a biological system
layer that naturally develops from the adhesion of micro-
organisms to the surface; these biofilms are related to
certain infectious diseases, and consequently to implant
failure (71).
Qiao et al. (72) proposed a three-dimensional printed
porous titanium alloy (Ti6Al4V) embedded in an antibac-
terial hydrogel to prevent infections. The porous structure
made the implant more compatible with host bone tissue,
as it avoided stress-shielding and osteolysis. Furthermore,
the implant system demonstrated effective antibacterial
properties while inducing bone repair and osseointegra-
tion. This study shows that a non-degradable biomaterial
can be associated with a degradable one to enhance
tissue repair.
Therefore, the superficial modification of metallic
implants is essential for improving their electrochemical
performance, biocompatibility, and osseointegration proc-
ess, with the aim of increasing their long-term stability as a
biomaterial (73).
Surface treatments
Several processes to alter the surface characteristics
of metallic implants in order to improve adaptation to bone
tissue after implantation have been used.
The surface of metals can be modified with inorganic
coatings such as CaP. These kinds of coatings allow
for enhanced corrosion resistance, reduced metal ion
release, and osteoblast attachment promotion. Oliveira
and colleagues evaluated a nano-hydroxyapatite coated
implant in diabetic rats, showing a statistically signifi-
cant difference in gene expression of osteogenic markers
Runx2, alkaline phosphatase, osteopontin, and osteocal-
cin in the early stage of osseointegration (74). Mokabber
and colleagues developed a silver/calcium phosphate
coating via electrochemical deposition on titanium sub-
strates. The biomaterial showed bacterial reduction and
excellent compatibility when silver ions were deposited as
metallic silver nanoparticles on the CaP coating (75).
Besides the CaP-based coatings, other inorganic coatings
have been proposed such as glass ceramics, zeolites,
and carbon, which possess great potential for bone tissue
engineering.
Composite coatings have also been proposed to
obtain enhanced bone regeneration properties, and they
can usually be combined with inorganic coatings. Yu et al.
(76) coated Ti-Al-4V substrates with collagen-HA compo-
sites, resulting in a slightly higher osteoblast proliferation
rate compared with HA coating.
Figure 5. Graph showing metals distribution in publications
retrieved from a search in the PubMed database using the
following terms: ‘‘Titanium’’, ‘‘Silver’’, ‘‘Magnesium’’, ‘‘Niobium’’,
‘‘Strontium’’, ‘‘Stainless Steel’’ and ‘‘Cobalt’’. Each term has
been associated with ‘‘AND ‘‘Bone Regeneration’’ [MeSH].
June 1, 2020.
Braz J Med Biol Res | doi: 10.1590/1414-431X2021e11055
Biomaterials for bone regeneration 9/15
Organic materials such as synthetic and natural
polymers can be used as coatings for metallic implants.
Polymers can prevent the corrosion of the implant, in
addition to improving cell viability and adhesion. Also,
polymer coatings could be used for the release of drugs
that could contribute to the osseointegration of the
implant. Therefore, anti-inflammatories have been pro-
posed to prevent the aseptic loosening of orthopedic
implants (77). Aseptic loosening is a frequent problem that
occurs when particles are worn away from the implant
surface and stimulate aseptic inflammatory responses for
the phagocytosis of those small wear particles. Moreover,
polymer coatings for the release of drugs that could
support bone formation, such as alendronate and albumin,
have been proposed (78).
On the other hand, the electrochemical treatments
of electropolishing and anodizing, coatings obtained by
plasma electrolytic oxidation, silane hybrid coatings by
sol-gel, and plasma polymerization are prominent for
application in the area of tissue regeneration.
In the electropolishing process, an anodic leveling and
anodic brightening of the surface is made to reduce the
roughness and improve the resistance to corrosion (79).
This is considered an electrochemical process carried out
through the use of the metallic substrate as a working
electrode for polishing the metal (80). This process is
performed using a voltage source that produces an
electric current that passes from the anode to the cathode,
resulting in the oxidation of the metal and removal of
material from the surface at a controlled rate (81). The
amount of the removed metal depends on the electrolyte,
temperature, current density, and the metal to be electro-
polished (80).
The anodizing process aims to produce a stable
oxide layer that is firmly adhered to the metal substrate.
On titanium surfaces and their alloys, the formation of
this layer normally occurs with a nanometric and self-
organized topography as nanotubes, which has shown to
be a promising strategy for biological and osseointegration
processes (82). The main electrochemical parameters that
affect the formation of these porous structures are pH,
voltage, temperature, and the presence of impurities in
the material. The anodizing voltage itself mainly controls
the diameter of the pore or tube. At the beginning of the
electrochemical oxidation, the entire surface of the metal
is covered with a compact and uniform anodic oxide,
and following this, the layer begins to adsorb anions from
the solution, promoting the formation and growth of the
nanotubes (83).
The surface modification by plasma-assisted anodiz-
ing (PEO) treatment has been shown to be an innovative
technology for the biomedical field (84). It is considered
to be an electrochemical conversion treatment, which
provides the superficial formation of a metallic oxide layer.
It is a technique analogous to anodizing, but using higher
values of current potentials and current densities, which
causes a plasma formation on the sample surface. These
coatings offer some advantages such as the adjustment of
the elements incorporated into the metallic matrix and the
control of the microstructure according to thickness and
porosity (85).
Hybrid silane-based coatings combine organic and
inorganic silicon-based functional groups, whose general
formula is R’(CH2) nSi (OR) 3, where R’ is an organo-
functional group and R is a hydrolyzable alkoxy group.
When in contact with water, silanes are hydrolyzed to form
silanol groups (SiOH), which allow the bonding to the
hydrated metal surface (metal-OH) via the formation of
Si-O-metal bonds. The silanol groups undergo self-cross-
linking through siloxane (Si-O-Si) bonds, resulting in an
organic protection layer chemically bonded to the metallic
substrate (86). Specifically, many of these coatings are
being studied to improve the corrosion performance of
metallic prostheses or to functionalize their surfaces
through the incorporation of bioactive particles, biomole-
cules, drugs, and/or organic components dispersed in
silane precursors (70,87).
Another important application of silane coating in the
biomedical field is the release of silicon compounds by
hydrolytic degradation of the sol-gel network. The pres-
ence of the silicon element assists in the connective tissue
metabolism of bone and cartilage and is associated with
bone formation and calcification. In addition, silicon is
involved in collagen type I synthesis and osteoblastic
differentiation (88).
An advanced sol-gel technique is the application of
hybrid silane coatings by the plasma polymerization
technique, creating a film that protects the implant from
corrosion, as it can be highly cross-linked and insoluble.
The plasma can be used to chemically decompose the
silane precursor and as a source of an active species to
promote the formation of the film composition close to the
used monomer (precursor) (89). Important advantages of
this method are that it does not need toxic solvents,
precursors do not necessarily need to present unsatura-
tion to propagate the polymerization, and the adjustment
of the parameters used in the plasma allows for the control
of the properties of the resulting materials (thickness and
chemical composition) (90). It is noteworthy that the use of
alkoxysilane precursors stands out in this application
method, mainly due to vaporization at room temperature,
but some studies have been prioritizing the use of organo-
alkoxysilanes (89). In addition, thanks to easy thickness
control, nanoscale coatings can be obtained, which
consequently can favor protein interactions with bone
cells and cell differentiation.
Final considerations
Despite the great advances in bone tissue engineer-
ing, the translation of innovative bone healing strategies
to clinical applications still has a long way to go.
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The incorporation of cells has shown interesting results
for bone tissue regeneration, but cell therapies are difficult
to translate due to the complex regulatory barriers.
Furthermore, the preparation of cells before implantation
represents additional work, which is still not cost effective.
Currently, a large majority of studies have performed in
vivo tests with smaller animals such as rats and rabbits, but
testing these biomaterials in large animal models will be very
important to analyze their effects more appropriately.
Furthermore, in the field of dentistry, in which irregular-
shaped critical-size defects are common in the cranio-
facial region, the 3D printing technique will be relevant, but
the reduction of production costs will be necessary for
clinical implementation.
Another relevant point to consider is that the microbial
load in the oral cavity makes the development of scaffolds
with antimicrobial function for the control of the infection
and the promotion of bone formation critical.
Finally, since appropriate vascularization is indis-
pensable for osteogenic differentiation, it is important to
continue working on scaffolds that allow for vasculariza-
tion in order to obtain a fully mature bone.
With regard to metallic biomaterials, although there are
various surface modification techniques, many are costly
and difficult to execute, which limit their clinical translation.
Thus, it is important to look for simple and cost-effective
strategies to achieve osteoconductive surfaces that are
also capable of inhibiting the formation of biofilms.
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